Search

Your search keyword '"Rosati, Emanuela"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Rosati, Emanuela" Remove constraint Author: "Rosati, Emanuela" Database Unpaywall Remove constraint Database: Unpaywall
47 results on '"Rosati, Emanuela"'

Search Results

1. NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential

2. Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia

3. A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect

4. Therapeutic targeting of chronic lymphocytic leukemia by silver nanoparticles

5. Figure S10 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

6. Figure S4 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

7. Figure S5 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

8. Figure S2 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

9. Figure S5 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

10. Figure S1 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

11. Figure S3 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

12. Figure S6 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

13. Figure S8 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

14. Figure S9 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

15. Figure S7 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

16. Immune correlates of protection by vaccine against SARS‐CoV ‐2 in patients with chronic lymphocytic leukaemia

17. GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL

18. NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications

19. NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status

20. NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models

21. Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

22. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation

23. NOTCH and Graft-Versus-Host Disease

24. NOTCH1 Aberrations in Chronic Lymphocytic Leukemia

25. NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells

26. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia

27. Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation

33. Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction

34. γ‐Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down‐regulation

35. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation

38. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL

39. A new genetic lesion in B‐CLL: a NOTCH1 PEST domain mutation

41. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo

43. Graft engineering for allogeneic haploidentical stem cell transplantation

46. Group BStreptococcusInduces Apoptosis in Macrophages

Catalog

Books, media, physical & digital resources